Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
H Nakase, M Uchino, S Shinzaki, M Matsuura… - Journal of …, 2021 - Springer
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …
inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) …
Crohn's disease
Crohn's disease is an inflammatory bowel disease that is characterized by chronic
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn “der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten …
A Sturm, R Atreya, D Bettenworth… - Zeitschrift für …, 2022 - thieme-connect.com
Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
Almost all currently available treatments for inflammatory bowel disease (IBD) act by
inhibiting inflammation, often blocking specific inflammatory molecules. However, given the …
inhibiting inflammation, often blocking specific inflammatory molecules. However, given the …
Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes
RY Yangyang, JR Rodriguez - Seminars in pediatric surgery, 2017 - Elsevier
The incidence of inflammatory bowel disease (IBD) is rising with 25% of IBD diagnosed in
children under 18 years of age. The clinical presentation of IBD in children is often vague …
children under 18 years of age. The clinical presentation of IBD in children is often vague …
Crohn's disease
J Torres, S Mehandru, JF Colombel, L Peyrin-Biroulet - The Lancet, 2017 - thelancet.com
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, with
increasing incidence worldwide. Crohn's disease might result from a complex interplay …
increasing incidence worldwide. Crohn's disease might result from a complex interplay …
Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission …
G D'Haens, S Vermeire, G Lambrecht, F Baert… - Gastroenterology, 2018 - Elsevier
Background & Aims A combination of infliximab and immunomodulators is the most
efficacious treatment for Crohn's disease (CD). Patients have the best outcomes when their …
efficacious treatment for Crohn's disease (CD). Patients have the best outcomes when their …
Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis …
A Cholapranee, GS Hazlewood… - Alimentary …, 2017 - Wiley Online Library
Background Mucosal healing is an important therapeutic endpoint in the management of
Crohn's disease (CD) and ulcerative colitis (UC). Limited data exist regarding the …
Crohn's disease (CD) and ulcerative colitis (UC). Limited data exist regarding the …
Deep remission at 1 year prevents progression of early Crohn's disease
Background & Aims We investigated the effects of inducing deep remission in patients with
early Crohn's disease (CD). Methods We collected follow-up data from 122 patients (mean …
early Crohn's disease (CD). Methods We collected follow-up data from 122 patients (mean …
Serum biomarkers for inflammatory bowel disease
P Chen, G Zhou, J Lin, L Li, Z Zeng, M Chen… - Frontiers in …, 2020 - frontiersin.org
Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative
colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel …
colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel …